The European Parliament gave a resounding endorsement of Tomislav Sokol’s (EPP, Croatia) report on the Critical Medicines Act (CMA), setting out the Parliament’s battle lines for...
Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe. US tariffs and...
